Bioavailability of two different formulations of coenzyme Q10 in healthy subjects

Asia Pacific Journal of Clinical Nutrition

Volumn 7, Issue 1, 1998, Pages 37-40

  Wahlqvist, M L ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Bioavailability; Coenzyme q10; Emulsion dosage form; Ubiquinone

Indexed keywords

EID: 22044443079     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinon function. Biochim Biophys Acta 1995; 1271: 195-204.
2. 10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim Biophys Acta 1992; 1126:247-254.
3. Kontush A, Hübner C, Finckh B, Kohlschütter A, Beisiegel U. Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid content. FEBS Lett 1994; 341:69-73.
4. Kontush A, Hübner C, Finckh B, Kohlschütter A, Beisiegel U. Antioxidative activity of ubiquinol-10 at physiolgic concentrations in human low density lipoprotein. Biochim Biophys Acta 1995; 1258: 177-187.
5. Kalén A, Appelkvist E, Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids 1989; 24: 579-584.
6. Söderberg M, Edlund C, Kristensson K, Dallner G. Lipid composition of different regions of the human brain during aging. J Neurochem 1990; 54: 415-123.